Development and characterization of an Indacaterol/Tiotropium Bromide composite dry powder inhalation formulation for COPD
Pharmaceutical Science Advances · 2026-12 · 4 · 100136
DOI: 10.1016/j.pscia.2026.100136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Science Advances, 2026-12. Verfasst von Xiaobing Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Institute for Food and Drug Control, Jinan, Shandong, 250101, China. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Taishan Industry Leading Talents.
Themen: COPD
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shandong Institute for Food and Drug Control, Jinan, Shandong, 250101, China.
- School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.
- Industrial Technology Foundation Public Service Platform, Jinan, Shandong, 250101, China.
- College of Chemistry, Beijing Normal University, Beijing, 100875, China.
- Jewim Pharmaceutical (Shandong) Company Limited, Taian, Shandong, 271000, China.
Förderung
- Taishan Industry Leading Talents
Zitieren
APA
Wang, X., Xu, X., Cheng, C., Zheng, J., Liu, W., Xu, Y., Xu, J., Wu, L., Sun, X., Wang, W., & Fang, H. (2026). Development and characterization of an Indacaterol/Tiotropium Bromide composite dry powder inhalation formulation for COPD. Pharmaceutical Science Advances, 4, 100136. https://doi.org/10.1016/j.pscia.2026.100136
Vancouver
Wang X, Xu X, Cheng C, Zheng J, Liu W, Xu Y, et al. Development and characterization of an Indacaterol/Tiotropium Bromide composite dry powder inhalation formulation for COPD. Pharmaceutical Science Advances. 2026;4:100136. doi:10.1016/j.pscia.2026.100136
BibTeX
@article{Wang2026,
author = {Wang, Xiaobing and Xu, Xiaoxi and Cheng, Chunlei and Zheng, Jing and Liu, Wenkun and Xu, Yuwen and Xu, Jihang and Wu, Lihua and Sun, Xianhai and Wang, Weijian and Fang, Hao},
title = {Development and characterization of an Indacaterol/Tiotropium Bromide composite dry powder inhalation formulation for COPD},
journal = {Pharmaceutical Science Advances},
year = {2026},
volume = {4},
pages = {100136},
doi = {10.1016/j.pscia.2026.100136}
}
EUVIMED